Published in Urol Clin North Am on May 01, 1993
Growth hormone-releasing hormone antagonist MZ-4-71 inhibits in vivo proliferation of Caki-I renal adenocarcinoma. Proc Natl Acad Sci U S A (1997) 1.25
Targeted therapies for non-clear renal cell carcinoma. Target Oncol (2010) 1.02
Phase II clinical trial of capecitabine and gemcitabine chemotherapy in patients with metastatic renal carcinoma. Br J Cancer (2004) 1.00
Epigenetic regulation in RCC: opportunities for therapeutic intervention? Nat Rev Urol (2012) 0.99
Sorafenib after combination therapy with gemcitabine plus doxorubicine in patients with sarcomatoid renal cell carcinoma: a prospective evaluation. Eur J Med Res (2010) 0.97
Laparoscopic radical nephrectomy after shrinkage of a caval tumor thrombus with sunitinib. Nat Rev Urol (2009) 0.94
Autologous CIK cell immunotherapy in patients with renal cell carcinoma after radical nephrectomy. Clin Dev Immunol (2013) 0.87
Impact of genetics on the diagnosis and treatment of renal cancer. Curr Urol Rep (2011) 0.87
Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy. Nat Rev Urol (2009) 0.87
Systemic therapy for metastatic renal cell carcinoma: a review and update. Rev Urol (2012) 0.85
Increased interferon alpha receptor 2 mRNA levels is associated with renal cell carcinoma metastasis. BMC Cancer (2007) 0.85
Radiolabeled antibodies in renal cell carcinoma. Cancer Imaging (2007) 0.84
Other paradigms: growth rate constants and tumor burden determined using computed tomography data correlate strongly with the overall survival of patients with renal cell carcinoma. Cancer J (2009) 0.82
Targeted therapy for metastatic renal cell carcinoma: current treatment and future directions. Ther Adv Med Oncol (2010) 0.81
Increased serum hepcidin-25 level and increased tumor expression of hepcidin mRNA are associated with metastasis of renal cell carcinoma. BMC Cancer (2009) 0.81
The bevacizumab experience in advanced renal cell carcinoma. Onco Targets Ther (2010) 0.78
Microvessel density is high in clear-cell renal cell carcinomas of Ukrainian patients exposed to chronic persistent low-dose ionizing radiation after the Chernobyl accident. Virchows Arch (2012) 0.78
Identification of Pre- and Post-Treatment Markers, Clinical, and Laboratory Parameters Associated with Outcome in Renal Cancer Patients Treated with MVA-5T4. Front Oncol (2013) 0.78
Factors involved in treatment preference in patients with renal cancer: pazopanib versus sunitinib. Patient Prefer Adherence (2014) 0.77
Familial renal cancer: molecular genetics and surgical management. Int J Surg Oncol (2011) 0.76
Effects and Side Effects of Using Sorafenib and Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma. Int J Mol Sci (2017) 0.76
Phase II trial of irofulven (6-hydroxymethylacylfulvene) for patients with advanced renal cell carcinoma. Invest New Drugs (2001) 0.75
Immunotherapy of advanced renal cell carcinoma: Current and future therapies. Hum Vaccin Immunother (2016) 0.75
State-of-the-art treatment of metastatic renal cell carcinoma. Curr Oncol (2009) 0.75
Recombinant human interleukin 6 in metastatic renal cell cancer: a phase II trial. Br J Cancer (1996) 0.75
A phase II study of pyrazoloacridine in patients with advanced renal cell carcinoma. Invest New Drugs (1999) 0.75
Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature (1988) 6.12
Melanopsin and rod-cone photoreceptive systems account for all major accessory visual functions in mice. Nature (2003) 5.84
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82
Intensive versus standard case management for severe psychotic illness: a randomised trial. UK 700 Group. Lancet (1999) 4.54
Vibrio parahaemolyticus infections in the United States, 1973-1998. J Infect Dis (2000) 4.35
Handheld cellular telephone use and risk of brain cancer. JAMA (2000) 3.59
National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. The Gonococcal Isolate Surveillance Project. JAMA (1990) 3.25
Enteroaggregative Escherichia coli as a major etiologic agent in traveler's diarrhea in 3 regions of the world. Clin Infect Dis (2001) 3.08
Mapping of antigenic and functional epitopes on the alpha- and beta-subunits of two related mouse glycoproteins involved in cell interactions, LFA-1 and Mac-1. J Exp Med (1983) 2.78
Discrepancies in tuberculin skin test results with two commercial products in a population of intravenous drug users. J Infect Dis (1993) 2.77
Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy. Urology (1996) 2.77
Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor. J Immunol (1992) 2.64
pop-1 encodes an HMG box protein required for the specification of a mesoderm precursor in early C. elegans embryos. Cell (1995) 2.61
The role of Gulf Coast oysters harvested in warmer months in Vibrio vulnificus infections in the United States, 1988-1996. Vibrio Working Group. J Infect Dis (1998) 2.46
Cytotoxic chemotherapy for advanced hormone-resistant prostate cancer. Cancer (1993) 2.31
Costs and cost effectiveness of cardiovascular screening and intervention: the British family heart study. BMJ (1996) 2.27
Randomised controlled trial of treatment of chronic suppurative otitis media in Kenyan schoolchildren. Lancet (1996) 2.16
Randomized controlled trial of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: the POPMACT study. Psychol Med (2003) 2.16
Production of cloned pigs from in vitro systems. Nat Biotechnol (2000) 2.15
The response of symptomatic neurosyphilis to high-dose intravenous penicillin G in patients with human immunodeficiency virus infection. N Engl J Med (1994) 2.08
Frequency-Dependent Selection for Plasmid-Containing Cells of ESCHERICHIA COLI. Genetics (1979) 2.07
A dual-radioisotope technique for the evaluation of penile blood flow during tumescence. J Nucl Med (1992) 2.04
The 58,000-dalton cellular inhibitor of the interferon-induced double-stranded RNA-activated protein kinase (PKR) is a member of the tetratricopeptide repeat family of proteins. Mol Cell Biol (1994) 2.03
Perioperative corticosteroid supplementation and dento-alveolar surgery. Dent Update (2003) 2.02
Ethoxy-, pentoxy- and benzyloxyphenoxazones and homologues: a series of substrates to distinguish between different induced cytochromes P-450. Biochem Pharmacol (1985) 1.92
Decline in prevalence of neural tube defects in a high-risk region of the United States. Pediatrics (2000) 1.85
The pdr12 ABC transporter is required for the development of weak organic acid resistance in yeast. EMBO J (1998) 1.83
Chemotherapy for advanced renal-cell carcinoma: 1983-1993. Semin Oncol (1995) 1.83
Altered expression of the retinoblastoma gene product: prognostic indicator in bladder cancer. J Natl Cancer Inst (1992) 1.81
Cardiovascular risk factors for people with mental illness. Aust N Z J Psychiatry (2001) 1.81
Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver. Biochem Pharmacol (1994) 1.76
Aminopyridine block of transient potassium current. J Gen Physiol (1982) 1.73
Identification and regulation of the cystic fibrosis transmembrane conductance regulator-generated chloride channel. J Clin Invest (1991) 1.71
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivo. J Bone Miner Res (1997) 1.63
Towards a genetic dissection of the basis of triplet decoding, and its natural subversion: programmed reading frame shifts and hops. Annu Rev Genet (1991) 1.62
The 58-kilodalton inhibitor of the interferon-induced double-stranded RNA-activated protein kinase is a tetratricopeptide repeat protein with oncogenic properties. Proc Natl Acad Sci U S A (1994) 1.57
Effects of hypertonic saline, alternate day and daily rhDNase on healthcare use, costs and outcomes in children with cystic fibrosis. Thorax (2002) 1.54
Mutants of the RNA-dependent protein kinase (PKR) lacking double-stranded RNA binding domain I can act as transdominant inhibitors and induce malignant transformation. Mol Cell Biol (1995) 1.53
The nucleotide sequence of the first externally suppressible--1 frameshift mutant, and of some nearby leaky frameshift mutants. EMBO J (1983) 1.52
Presence of antibodies to the major anaerobically induced gonococcal outer membrane protein in sera from patients with gonococcal infections. Microb Pathog (1988) 1.48
Gender differences in smoking and risk for oral cancer. Cancer Res (1996) 1.47
Availability of on-site catheterization and clinical outcomes in patients receiving fibrinolysis for ST-elevation myocardial infarction. Eur Heart J (2001) 1.47
Obstacles to timely neonatal screening in North Thames. J Med Screen (1998) 1.47
Assessing the needs of breast cancer patients and their families. Qual Manag Health Care (1993) 1.43
Risk of squamous cell carcinoma and adenocarcinoma of the lung in relation to lifetime filter cigarette smoking. Cancer (1997) 1.42
Stimulus equivalence and rule following. J Exp Anal Behav (1989) 1.41
Manual-assisted cognitive-behaviour therapy (MACT): a randomized controlled trial of a brief intervention with bibliotherapy in the treatment of recurrent deliberate self-harm. Psychol Med (1999) 1.39
Science's great tragedy. Aust N Z J Public Health (1998) 1.39
Are herbal teas safe for infants and children? Aust Fam Physician (1989) 1.38
Mutants of elongation factor Tu promote ribosomal frameshifting and nonsense readthrough. EMBO J (1987) 1.36
A pharmacokinetic study of granisetron (BRL 43694A), a selective 5-HT3 receptor antagonist: correlation with anti-emetic response. Cancer Chemother Pharmacol (1989) 1.36
Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychol Med (2003) 1.35
Estramustine and vinblastine: use of prostate specific antigen as a clinical trial end point for hormone refractory prostatic cancer. J Urol (1992) 1.34
An N-Terminal Dimerization Domain Permits Homeodomain Proteins To Choose Compatible Partners and Initiate Sexual Development in the Mushroom Coprinus cinereus. Plant Cell (1995) 1.33
The psychological impact of cardiovascular screening and intervention in primary care: a problem of false reassurance? British Family Heart Study Group. Br J Gen Pract (1996) 1.31
Assessment of ventricular size and function in congenitally corrected transposition of the great arteries. Am J Cardiol (1983) 1.28
Handheld cellular telephones and risk of acoustic neuroma. Neurology (2002) 1.27
Disparity in glycemic control and adherence between African-American and Caucasian youths with diabetes. Family and community contexts. Diabetes Care (1997) 1.26
The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol (1991) 1.25
Aeolian processes at the Mars Exploration Rover Meridiani Planum landing site. Nature (2005) 1.23
Pleomorphic xanthoastrocytoma: favorable outcome after complete surgical resection. Neuro Oncol (2001) 1.22
Sound alters visual evoked potentials in humans. Neuroreport (2001) 1.22
Incentives and accessibility: a pilot study to promote adherence to TB prophylaxis in a high-risk community. J Urban Health (1999) 1.19
Characterization of the human trophoblast-leukocyte antigenic molecules defined by a monoclonal antibody. J Immunol (1986) 1.19
Cigarette smoking and tuberculin skin test conversion among incarcerated adults. Am J Prev Med (1997) 1.19
The role of epidermal aryl hydrocarbon hydroxylase in the covalent binding of polycyclic hydrocarbon to DNA and its relationship to tumor initiation. Biochem Biophys Res Commun (1976) 1.18
Novobiocin precipitates histones at concentrations normally used to inhibit eukaryotic type II topoisomerase. Nucleic Acids Res (1986) 1.17
Human erythrocyte fraction in "Percoll" density gradients. Clin Chim Acta (1979) 1.17
Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica. JAMA (1999) 1.16
Inhibition of HIV-1 replication by ribozymes that show poor activity in vitro. Nucleic Acids Res (1993) 1.14
Treating gonococcal infections resistant to penicillin in Bangkok: comparison of cefuroxime and spectinomycin. Genitourin Med (1985) 1.14
Acute leukemias of different lineages have similar MLL gene fusions encoding related chimeric proteins resulting from chromosomal translocation. Proc Natl Acad Sci U S A (1993) 1.11
Collaborative meta-analysis of individual participant data from observational studies of Lp-PLA2 and cardiovascular diseases. Eur J Cardiovasc Prev Rehabil (2007) 1.10
Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet (2001) 1.10
Paraplegia following intrathecal chemotherapy. Cancer (1972) 1.09
Unequal pupils. A flow chart for sorting out the anisocorias. Surv Ophthalmol (1976) 1.07
Changing pattern of expression of the epidermal growth factor receptor and transforming growth factor alpha in the progression of prostatic neoplasms. Clin Cancer Res (1995) 1.06
Water-borne outbreak of Campylobacter laridis-associated gastroenteritis. Lancet (1987) 1.06
p53, c-erbB-2 and the epidermal growth factor receptor in the benign and malignant prostate. J Urol (1992) 1.06
Silent lacunar lesions detected by magnetic resonance imaging of children with brain tumors: a late sequela of therapy. J Clin Oncol (2000) 1.06
A new percutaneous technique for establishing venous bypass access in orthotopic liver transplantation. J Cardiothorac Vasc Anesth (1994) 1.04
Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. Health Technol Assess (2004) 1.04
A prevalence study of ear problems in school children in Kiambu district, Kenya, May 1992. Int J Pediatr Otorhinolaryngol (1995) 1.03
Seven, eight and nine-membered anticodon loop mutants of tRNA(2Arg) which cause +1 frameshifting. Tolerance of DHU arm and other secondary mutations. J Mol Biol (1992) 1.03
Genetically modified keratinocytes transplanted to wounds reconstitute the epidermis. Proc Natl Acad Sci U S A (1994) 1.02
The changing epidemiology of human immunodeficiency virus infection in older persons. J Am Geriatr Soc (1995) 1.02
The adequacy of reimbursement for HIV under Section 1115 Medicaid waivers. AIDS Public Policy J (1997) 1.01
Evaluation of a university course to promote physical activity: project GRAD. Res Q Exerc Sport (1999) 1.01
Project GRAD: two-year outcomes of a randomized controlled physical activity intervention among young adults. Graduate Ready for Activity Daily. Am J Prev Med (2000) 1.00
Glycine tRNA mutants with normal anticodon loop size cause -1 frameshifting. Proc Natl Acad Sci U S A (1989) 1.00
The yield of head CT in syncope: a pilot study. Intern Emerg Med (2007) 0.99
Infectious mononucleosis in an outpatient population: diagnostic utility of 2 automated hematology analyzers and the sensitivity and specificity of Hoagland's criteria in heterophile-positive patients. Arch Pathol Lab Med (1999) 0.99
ELISPOT: a new approach to studying the dynamics of virus-immune system interaction for diagnosis and monitoring of HIV infection. AIDS Res Hum Retroviruses (1989) 0.99
Sorbitol-negative Escherichia coli O157 other than H7. J Infect (1989) 0.98
Nasogastric tube feeding at home: a method for adjunctive nutritional support of malnourished patients. Am J Clin Nutr (1981) 0.98